chrisvoncsefalvay/vaers-outcomes huggingface dataset:
08-02-2019 Office visit: History of Present Illness: Rash:  The patient presents for rash.  This episode began gradually and has lasted caries.  The symptom(s) are described as moderate, unchanged and occurs daily.  The patient describes the affected area(s) as burning, itchy and red.  Associated symptoms include erythema (skin) and pruritus.  States had Tdap injection on 7/22 [given in R deltoid] and states ever since has had a rash on her arm.  Says it is hot, painful, and will not go away.  States she also felt somewhat sick for 2 days after.  Review of Systems: Integumentary:  Positive for erythema, pruritis  Assessment and Plan:  Rash.  Please take the steroids and antibiotic.  If you do not improve let us know.  (Prednisone 20 mg.  Take 2 tabs by mouth once daily for 4 days, take 1 tab daily for 3 days;  cephalexin 500 mg.  Take 1 capsule by oral route 3 times every day.  Dispense 21 capsules.)  10-03-2019 Outgoing call at 4:08 PM:  I called to follow-up on the rash on arm from a Tdap administration on 7-22.  To see that is has fully resolved and about how long it took to do that.  This is my third day/attempt to contact patient and each time a recording says mailbox is full. 10-04-2019 at 9:08 AM:  I called and mailbox is full.  All communications since the OV re: arm/rash have nothing to do about arm/rash.  I will fill out VEARS report.
I had no initial symptoms. On day 7, I noticed two lumps on my left collar bone. I have a bigger lump and a smaller lump. They were not there before and I check those areas constantly because of a previous diagnosis of thyroid cancer 2 years ago that was treated. I also had a thyroid ultrasound and Complete Blood Draw about a month before my COVID19 vaccine and my labs and ultrasound was normal.
Pt states that her back was stiff and was having pain in it. Pt could hardly stand and states she felt "paralyzed". This nurse got an EKG that showed normal sinus rhythm and I got the Dr. the Dr. came in and stated he was worried that it might have been related to spinal stenosis so instructed pt and husband to go to ER, that he did not think that it was realted to the vaccine at all but due to the spinal stenosis. Pt and husband did go to ER but left AMA.
Moderna x 2. Tested positive for Covid 19 on 02/14/2022. Expired at Medical Center ED on 04/02/2022.
CRUSHING CHEST PAIN 2 HOURS AFTER SHOT.  DID NOT GO TO ER BUT FELT LIKE SHE WAS GOING TO DIE.  DID GO TO PCP AND EKG/LABS WERE NORMAL.
Pt has persistent right shoulder pain s/p her 1st Moderna shot in March 2021.  She had no problems with her 2nd shot (in her left shoulder), in April.
Patient received Moderna COVID vaccine on 5/8/21 and 6/5/21. On 1/30/22, patient admitted to our inpatient facility with COVID19 related generalized weakness, cough, nasal congestion, and hyponatremia secondary dehydration. As of today (2/1/22), patient is still admitted in the med/surg unit.
Bell's palsy; This is a spontaneous report from a contactable healthcare professional.  A 46-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number/expiration date not reported), via an unspecified route of administration, administered in left arm on 26Feb2021 as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced bell's palsy on 01Mar2021. The event was reported to have resulted in emergency room/department or urgent care visit. The outcome of the event was unknown.  Information about lot/batch number has been requested.; Sender's Comments: Based on the reasonable temporal association, the known safety profile of the COVID-19 vaccine, and lacking alternative explanations, the Company cannot completely exclude the possible causality between the reported bell's palsy and the suspect administration.   The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RA, IEC, as appropriate.
Day of 1st vaccine I experienced some slight upper leg soreness ( and soreness at injection site).  Over the next month, my leg/hip pain became worse.   Day of 2nd vaccine, I experienced fever of 101-102 for approximately 2 days.  Since then, my leg hip pain has continually worsened.  For the past year I have walked approx. 2.5-3 miles a day and exercised several times a week with hand weights, ankle weights, sit up, plank, yoga moves, etc.  I am not overweight and am in excellent health for a person of my age. Pain is sometimes excruciating, especially when squatting down to the floor or getting up out of a chair.  Always feel hip pain on my walks.
1 day after 4th dose DTAP, patients left thigh was swollen x 2 cm diameter.  More than the other.  No redness, no streaking, no fever.  72 hours of localized swelling.
she received Shingrix at the same time; she received Shingrix at the same time; in bed all day feeling achy and with a headache; in bed all day feeling achy and with a headache; This is a spontaneous report received from contactable reporter(s) (Nurse). The reporter is the patient.  A female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), in 2022 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; varicella zoster vaccine rge (cho) (SHINGRIX), in 2022 as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary immunization series complete; Unknown manufacturer), for COVID-19 immunization. The following information was reported: PAIN (non-serious), HEADACHE (non-serious) all with onset 2022, outcome "not recovered" and all described as "in bed all day feeling achy and with a headache"; OFF LABEL USE (non-serious), PRODUCT USE ISSUE (non-serious) all with onset 2022, outcome "not recovered" and all described as "she received Shingrix at the same time". Additional information: Nurse stated that she received Pfizer Bivalent booster recently and was in bed all day feeling achy and with a headache. She also stated that she received Shingrix at the same time. The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
1/25/21 received vaccine; mins after paramedics called pt was experiencing blackout, blood pressure high, high heart rate, heart flip flops,  weak, tingling hands/feet, difficulty breathing, cough to be able to breath, chest pains, splotchy skin areas, brain fog, hot/cold, happens every morning since besides 1/28/21 takes two hours to shake, symptoms returned 1/29/21 morning.
Sudden Bp drop; feeling hot and faint; nauseous; both hands to the middle of forearm felt ?asleep? and tingling; extreme sweating, all lasted roughly 20 mins.
Moderna vaccination booster was given 1 month before due date. Moderna booster was due 11/24/2021. Client was notified at 5:30 pm on 10/25/2021 .  On 10/26/2021 Client was contacted for follow-up and stated only sore arm from vaccination.
redness in bilateral thigh, fever, very irritable, cranky. The next morning after being given vaccine.
Day after shot (9/1) -- 1. Low-grade fever (100.4) 2. Extreme nausea 3.  Itchy and painful rash on left arm 4. Elevated heart rate (typical previous resting heart rate at 59, now current resting heart rate does not go below 80)  As of 9/13/2021, rash and elevated heart rate continue to be present.
pt recv vax;c/o feeling feverish w/ general malaise,d&stomach cramps which lasted until next am;
hot; Hardness; slight itching; Redness/ size of dollar bill and blotchy; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (hot), INJECTION SITE INDURATION (Hardness), INJECTION SITE PRURITUS (slight itching) and INJECTION SITE ERYTHEMA (Redness/ size of dollar bill and blotchy) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced INJECTION SITE WARMTH (hot), INJECTION SITE INDURATION (Hardness), INJECTION SITE PRURITUS (slight itching) and INJECTION SITE ERYTHEMA (Redness/ size of dollar bill and blotchy). On 04-Feb-2021, INJECTION SITE WARMTH (hot), INJECTION SITE INDURATION (Hardness), INJECTION SITE PRURITUS (slight itching) and INJECTION SITE ERYTHEMA (Redness/ size of dollar bill and blotchy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.~  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: TCR - event outcome added
About 24  hours after receiving the shot I am experiencing some swelling and extreme itching in hands and fingers. As time has progressed the swelling has gone away entirely but I am now experiencing itching along with visible hives on both wrists, inner thighs, and inner arms at the elbow.
Reported erythema, mild to moderate swelling, warmth, and tenderness at the injection site.
Patient recieved the vaccine then went to buy a gatorade and a snickers then went to the front of the store, felt strange and passed out. He later told us he has a history of fainting near needles (tattoos, piercings, vaccinations)
The Day after the injection I had full body muscle aches, reddness at injection site.    The 2nd Day after the injection, my muscle aches are better but now my Lymph Node under my arm is very swollen and painful
Wife got her Fluzone HD shot first and then I gave her husband his Fluzone HD and his first Shingrix shot. Patient reported symptoms 10-15 minutes after receiving her Fluzone HD shot. Patient had some difficulty breathing, skin was clammy to touch, reported leg pain, back pain and chest pain. Before paramedics arrived she started feeling a little better with her leg pain and back pain. When husband notified of adverse event we contacted 911 immediately and asked paramedics to come to pharmacy to check patient. Patient's son arrived the same time paramedics came.
I got the Zoster Vaccine for shingles prevention. In both cases, I began with fatigue, then extreme body aches, and high fever. Both nights after the vaccine. I wondered if I was going to actually make it through the night. My body shook uncontrollably all night long. I felt I might need to be rushed to the hospital but I battled it out and hope for the best.. This only happened the first night for BOTH vaccines. The next two days on both occasions, I was highly fatigued and had a headache. I was in real fear that I would live through those two nights. These horrible nights were on 04/02/2019 with the first dose and on 06/26/2019 with the second dose.
Child became pale and sweaty.  Temp: 98.8, BP: 90/68, P: 70
recv vax 28FEB AM & woke up next morning w/muscle weakness over entire body & extreme fatigue;also numbness in bottom of feet;saw local MD sx cont & was then seen by a neuro dx GBS
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 23Sep2022 at 12:00 as dose 5 (booster), single (Lot number: GH9702) at the age of 52 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 09Mar2021 at 12:00 as dose 1, single (Lot number: EN6206), in left arm, on 30Mar2021 at 12:00 as dose 2, single (Lot number: ER8727), in left arm, on 29Nov2021 at 12:00 as dose 3 (booster), single (Lot number: FP4554), in left arm and on 15Apr2022 at 12:00 as dose 4 (booster), single (Lot number: FP4554), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: penicillin" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2022) Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of vaccination failure, covid-19 which included Paxlovid from 03Dec2022 to 07Dec2022.
Patient was given expired hep B.  vaccine.  Vaccine given on 10/12/22.  The expiration for the vaccine was 10/08/22 (expired by 4 days).  The Provider and Patient was notified right away.
Information has been received from a registered pharmacist concerning a patient who was vaccinated intradermally with a dose of pneumococcal vaccine 23 polyvalent, "believing this to be TB".  It was reported that there were "no untoward reactions at present".  Subsequently, it was reported that the only adverse experience was a "small, raised, red area" at the injection site.  Unspecified medical attention was sought.  Follow-up information indicated that the vaccination was given in error and was not the result of any "similarity of product, packaging or name".  Additional information has been requested.
Severe headache; Nausea; Myalgia; sore/itchy throat; Sore/itchy throat; Fever and chills within 3-4 post vaccination; Fever and chills within 3-4 post vaccination; This is a spontaneous report from a contactable healthcare professional who reported for herself, a 21-year-old female patient who received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and expiration date unknown), intramuscular in the right arm, on 30Jan2021 at 18:30, at the age of 21 years, at a single dose for COVID-19 immunization. Medical history included asthma, and known allergies to azithromycin (ZITHROMAX) and sulfa. The patient was not pregnant, and not pregnant at time of vaccination. The patient's concomitant medications were not reported. The patient previously received the first dose of BNT162B2 on an unspecified date for COVID-19 immunization. On 30Jan2021 at 21:30, the patient experienced fever and chills within 3-4 post vaccination. The patient experienced severe headache, nausea, myalgia, and sore/itchy throat the next day, on 31Jan2021. No treatment was received for the events. Patient had no COVID prior vaccination, and was not COVID tested post vaccination. The outcome of the events was recovering.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
Patient complained of difficulty swallowing, tingling feeling in her tongue. She initatally took 50 mg of benedryl, and after 15 more minutes, she continued to have the same symptoms, and in addition was breathing more labored, was having a harder time swallowing, and complaining of feeling dizzy and a headache. She then received an Epi Pen, was placed on oxygen, used her Xopenex inhaler, and EMS was called. She was then transferred to the ED for continued monitoring.
This spontaneous report was received from a pharmacist regarding a 50 year old male patient. The patient was vaccinated with a single dose of ZOSTAVAX, 0.65 mL on 10-SEP-2012. On the same day (10-SEP-2012) and in the same arm, the patient also received an unknown dose of ADACEL. The pharmacist reported that the patient was very thin and muscular, with very little subcutaneous tissue and was concerned that the ZOSTAVAX might have been injected into muscle tissue rather than subcutaneous tissue. On 11-SEP-2012, the patient developed a mild fever and became tired and weak after receiving ZOSTAVAX. The pharmacist also reported that the patient developed redness on his arm at the injection site after receiving ZOSTAVAX. The patient sought medical attention reported as he called the pharmacist and the pharmacist went out to see the patient. No treatment reported. The patient recovered from the events on an unspecified date. Additional information has been requested.
"felt really bad"; "didn't sleep well that evening"; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL ("felt really bad") and INSOMNIA ("didn't sleep well that evening") in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Psoriasis. Concomitant products included USTEKINUMAB (STELERA) for Psoriasis.   On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-May-2021, the patient experienced FEELING ABNORMAL ("felt really bad") and INSOMNIA ("didn't sleep well that evening"). The patient was treated with IBUPROFEN at a dose of 1 dosage form. On 09-May-2021, FEELING ABNORMAL ("felt really bad") and INSOMNIA ("didn't sleep well that evening") had resolved.            Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: TCR Attached ,Event outcome is updated
Sudden onset of both severe HTN and severe tinnitus 36 hours after dose #2.  BP taken with regular use cuff and was 210/175 and tinnitus used to wax and wane in past but no problems, and this acute on chronic onset was severe, 24/7, non-stop and interferes primarily with sleep. Very loud non-stop bilateral tinnitus. I treated elevated BP for 2 weeks with Losartan 25 mg qd, then daily BP came back to normal and Losartan stopped. Tinnitus has not changed.
Developed febrile illness shaking, chills, rigors, temp of 102 F on 10/27/2005. By 10/31/2005 he had developed a rash that became confluent in lower trunk. He had fever, aches, myalgias, rash progressed to entire body. Headache but no joint inflammatory symptoms. No reaction in wife or son. -12/15/05 Review of medical record related to initial hospitalization of 11/1/05-11/4/05 indicates final diagnoses of 'serum sickness reaction ? to flu shot' and paroxysmal atrial fibrillation. Other symptoms noted were decreased appetite, arthralgia, sore throat, postnasal drip. 12/15/05 Review of discharge summary for hospitalization from 11/8/05 - 11/14/05 indicates final diagnosis of acute MI, s/p stent placement with improving CHF.
Received my flu vaccine Monday and since then I?ve been experiencing some issues with my shoulder joint. Specific details include decreased ROM, sharp shooting pains, popping in the joint with pain and ?zinging? with movement. The best way I can describe it is it feels like my shoulder is subluxed and being impinged with movement.
Patient developed a diffuse rash on trunk 3d after varicella vaccine. Supportive management cancelled 2nd varicella vaccine.
7/25 pt hosp w/rt lower lobe pneumonia; records reveals pt presented w/congestion, wheezing, green exudates & fever; tx w/ATBs, pediazole, ibuprofen, Pedia-Pred & albuterol;
Rash, fever. Rash at site initially - then rash on arms/legs.
within 5 minutes, developed hives and redness at site where shot was given. Observed in office for about 10 minutes with worsening. At home mother gave 1 dose Benadryl and observed . Hives did not worsen and dissappeared completely by 3:00 P.M.
Patient states arm swollen. At first thought it normal side effect, but can't lift above shoulder. It is worsening he states today.
rash at injection site the size of a fist; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash at injection site the size of a fist) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced VACCINATION SITE RASH (rash at injection site the size of a fist). At the time of the report, VACCINATION SITE RASH (rash at injection site the size of a fist) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported. No Treatments were reported.
Not sure if those were the exact as they didn?t give me full info just told me the d tap was a mixture of multiple shots.
approx 3hr p/vax pt awoke w/t102.8, vomiting, limpness;pt had recv APAP @ time of vax;pt visited MD office-was given Ibuprofen;
Onset of dizziness (6/25). Severe dizziness with vomiting 7/2, 10 days post vaccination. Intermittent dizziness continuing without vomiting. Slight confusion and disorientation. Warmness in the face but no fever. BP and O2 normal.
I still have a bad cough; Raw throat feeling; Cough hurts me in my chest; This case was reported by a consumer via interactive digital media and described the occurrence of cough in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced cough, raw throat and chest pain. On an unknown date, the outcome of the cough, raw throat and chest pain were not recovered/not resolved.   It was unknown if the reporter considered the cough, raw throat and chest pain to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The reporter reported his/her symptoms dissipated after second vaccine shot, the patient still had a bad cough and raw throat feeling. The cough hurt in chest as well and reporter wanted help
Experienced very sore calf within 2 weeks of vaccine but thought it was from snowshoeing. Then on April 8 I developed vein inflammation in two areas. An ultrasound on April13 showed two blood clots.  One superficial and one dvt
redness/swelling/firm/tenderness at injection site, lymphadenopathy. starting day 8 post vaccine
arm has swollen up; had a really bad day. He thought it would go down; has knots in his left arm / it is like a golf ball on his arm; was also real sick; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm has swollen up), FEELING ABNORMAL (had a really bad day. He thought it would go down), SKIN MASS (has knots in his left arm / it is like a golf ball on his arm) and ILLNESS (was also real sick) in a 73-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037K20A, 041L20A1 and 088D21A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (arm has swollen up), FEELING ABNORMAL (had a really bad day. He thought it would go down), SKIN MASS (has knots in his left arm / it is like a golf ball on his arm) and ILLNESS (was also real sick). At the time of the report, PERIPHERAL SWELLING (arm has swollen up), FEELING ABNORMAL (had a really bad day. He thought it would go down) and SKIN MASS (has knots in his left arm / it is like a golf ball on his arm) outcome was unknown and ILLNESS (was also real sick) had resolved.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable  Treatment included a cold wash cloth was put on the patient's arm. No concomitant medications reported.
Reaction started after 2nd dose-Pain in arm, chills, and severe shaking. Headaches.